Prasugrel for Prevention of Early Saphenous Vein Graft Thrombosis

Trial Profile

Prasugrel for Prevention of Early Saphenous Vein Graft Thrombosis

Completed
Phase of Trial: Phase III

Latest Information Update: 15 Jun 2018

At a glance

  • Drugs Prasugrel (Primary) ; Aspirin
  • Indications Coronary thrombosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Jun 2018 Status changed from active, no longer recruiting to completed.
    • 05 Apr 2018 Planned End Date changed from 30 Apr 2018 to 31 May 2018.
    • 19 Oct 2017 Planned number of patients changed from 120 to 84.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top